✦ LIBER ✦

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

✍ Scribed by Pratley, Richard E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of alogliptin, a d

✍ Christopher, Ronald; Karim, Aziz 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 691 KB

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Dr. Joshua J. Neumiller; Dr. Lindy Wood; Mr. R. Keith Campbell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

The dipeptidyl peptidase-4 inhibitor alo

✍ Fujii, Yuki; Abe, Masanori; Higuchi, Terumi; Mizuno, Mari; Suzuki, Hiroko; Matsu 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 379 KB

Dipeptidyl peptidase inhibitors as new d

✍ H.-J. Mest; R. Mentlein 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 119 KB

Sitagliptin: A Dipeptidyl Peptidase IV I

✍ Miller, S. A 📂 Article 📅 2006 🏛 Harvey Whitney Books Company 🌐 English ⚖ 137 KB